SI3424932T1 - Boronoftalidi za terapevtsko uporabo - Google Patents

Boronoftalidi za terapevtsko uporabo

Info

Publication number: SI3424932T1
Authority: SI; Slovenia
Prior art keywords: boronophthalides; therapeutic use; therapeutic
Prior art date: 2005-02-16

Application number

SI200632404T

Other languages

English (en)

Inventor

Stephen Baker

Tsutomu Akama

Carolyn Bellinger-Kawahara

Vincent Hernandez

Karin Hold

James Leyden

Kirk Maples

Jacob J Plattner

Virginia Sanders

Yong-Kang Zhang

Original Assignee

Anacor Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-16

Filing date

2006-02-16

Publication date

2021-08-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36917059&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3424932(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-02-16 Application filed by Anacor Pharmaceuticals, Inc. filed Critical Anacor Pharmaceuticals, Inc.

2021-08-31 Publication of SI3424932T1 publication Critical patent/SI3424932T1/sl

Links

SDFFFSHXRFEUAD-UHFFFAOYSA-N (3-oxo-1h-2-benzofuran-1-yl)boronic acid Chemical class C1=CC=C2C(B(O)O)OC(=O)C2=C1 SDFFFSHXRFEUAD-UHFFFAOYSA-N 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/05—Cyclic compounds having at least one ring containing boron but no carbon in the ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Biotechnology (AREA)
AIDS & HIV (AREA)
Ophthalmology & Optometry (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SI200632404T 2005-02-16 2006-02-16 Boronoftalidi za terapevtsko uporabo SI3424932T1 (sl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US65406005P	2005-02-16	2005-02-16
EP18187390.2A EP3424932B1 (en)	2005-02-16	2006-02-16	Boronophthalides for therapeutic use

Publications (1)

Publication Number	Publication Date
SI3424932T1 true SI3424932T1 (sl)	2021-08-31

Family

ID=36917059

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
SI200632404T SI3424932T1 (sl)	2005-02-16	2006-02-16	Boronoftalidi za terapevtsko uporabo
SI200632291T SI2987796T1 (sl)	2005-02-16	2006-02-16	Halogen-substituirani boronoftalidi za zdravljenje okužb
SI200631937T SI2343304T1 (sl)	2005-02-16	2006-02-16	Biocidne boroftalidne spojine

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
SI200632291T SI2987796T1 (sl)	2005-02-16	2006-02-16	Halogen-substituirani boronoftalidi za zdravljenje okužb
SI200631937T SI2343304T1 (sl)	2005-02-16	2006-02-16	Biocidne boroftalidne spojine

Country Status (26)

Country	Link
US (11)	US7582621B2 (sl)
EP (4)	EP2987796B1 (sl)
JP (6)	JP5038912B2 (sl)
KR (4)	KR101426220B1 (sl)
CN (2)	CN101160124A (sl)
AU (3)	AU2006214247C1 (sl)
BR (1)	BRPI0608431B8 (sl)
CA (1)	CA2597982C (sl)
CY (3)	CY1120695T1 (sl)
DK (3)	DK2987796T3 (sl)
ES (4)	ES2872962T3 (sl)
FR (1)	FR20C1024I2 (sl)
HK (3)	HK1109735A1 (sl)
HU (4)	HUE040060T2 (sl)
IL (2)	IL185080A (sl)
LT (1)	LTC2343304I2 (sl)
LU (1)	LUC00157I2 (sl)
MX (1)	MX369262B (sl)
NL (1)	NL301049I2 (sl)
NZ (3)	NZ560448A (sl)
PL (4)	PL2343304T3 (sl)
PT (4)	PT3424932T (sl)
RU (3)	RU2414906C2 (sl)
SI (3)	SI3424932T1 (sl)
WO (1)	WO2006089067A2 (sl)
ZA (4)	ZA200707408B (sl)

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7820186B2 (en) *	2001-12-21	2010-10-26	Galderma Research & Development	Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
SI3424932T1 (sl) *	2005-02-16	2021-08-31	Anacor Pharmaceuticals, Inc.	Boronoftalidi za terapevtsko uporabo
US7793666B2 (en) *	2005-07-28	2010-09-14	Innovation Biomedical Devices, Inc.	Apparatus and method for treatment of infected nail
RU2008131324A (ru)	2005-12-30	2010-02-10	Анакор Фармасьютикалз, Инк. (Us)	Борсодержащие малые молекулы
MX2008010381A (es) *	2006-02-16	2009-03-05	Anacor Pharmaceuticals Inc	Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
BRPI0711155A2 (pt) *	2006-05-02	2011-08-23	Anacor Pharmaceuticals Inc	terapêuticos contendo boro resistentes hidroliticamente e métodos de uso
EP1900378A1 (en) *	2006-08-31	2008-03-19	Novartis AG	Pharmaceutical compositions for the treatment of fungal infections
JO3598B1 (ar)	2006-10-10	2020-07-05	Infinity Discovery Inc	الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
FR2910321B1 (fr)	2006-12-21	2009-07-10	Galderma Res & Dev S N C Snc	Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) *	2006-12-21	2009-02-13	Galderma Res & Dev S N C Snc	Emulsion comprenant au moins un retinoide et du peroxyde de benzole
JO3396B1 (ar) *	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
US20090175810A1 (en)	2008-01-03	2009-07-09	Gareth Winckle	Compositions and methods for treating diseases of the nail
JP2015178508A (ja) *	2008-01-09	2015-10-08	アナコールファーマシューティカルズ，インコーポレイテッド	抗炎症剤としてのホウ素含有小分子
WO2009111676A2 (en) *	2008-03-06	2009-09-11	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-inflammatory agents
US8039450B2 (en)	2008-03-06	2011-10-18	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-inflammatory agents
JP5637982B2 (ja) *	2008-04-09	2014-12-10	インフィニティーファーマシューティカルズ，インコーポレイテッド	脂肪酸アミド加水分解酵素の阻害剤
US20100256092A1 (en) *	2008-05-12	2010-10-07	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010011354A2 (en) *	2008-07-25	2010-01-28	Innovation Biomedical Devices, Inc.	Enchanced trans-keratin drug delivery
WO2010028005A1 (en)	2008-09-04	2010-03-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
EP2348863A4 (en)	2008-09-04	2012-03-07	Anacor Pharmaceuticals Inc	BORN SMALL MOLECULES
WO2010045503A1 (en)	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agents
KR20110111407A (ko) *	2008-12-17	2011-10-11	아나코르 파마슈티칼스 인코포레이티드	(ｓ)-３-아미노메틸-７-(３-히드록시-프로폭시)-３ｈ-벤조〔ｃ〕〔１,２〕옥사보롤-１-올의 다형태
US8546564B2 (en)	2009-04-07	2013-10-01	Infinity Pharmaceuticals, Inc.	Inhibitors of fatty acid amide hydrolase
JP2012523425A (ja)	2009-04-07	2012-10-04	インフイニトイプハルマセウトイカルスインコーポレイテッド	脂肪酸アミドヒドロラーゼの阻害薬
EP2458995A1 (en)	2009-07-28	2012-06-06	Anacor Pharmaceuticals, Inc.	Trisubstituted boron-containing molecules
WO2011019616A1 (en)	2009-08-14	2011-02-17	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
WO2011019612A1 (en)	2009-08-14	2011-02-17	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
US9440994B2 (en) *	2009-08-14	2016-09-13	Anacor Pharmaceuticals, Inc.	Boron containing small molecules as antiprotozoal agents
MX2012002031A (es) *	2009-08-19	2012-07-04	Anacor Pharmaceuticals Inc	Moleculas pequeñas que contienen boro como agentes antiprotozoarios.
US20110124597A1 (en) *	2009-09-25	2011-05-26	Anacor Pharmaceuticals, Inc.	Boron containing small molecules
US8979820B2 (en)	2009-10-09	2015-03-17	Cynthia S. Bailey	Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes
US9346834B2 (en)	2009-10-20	2016-05-24	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
WO2011060196A1 (en)	2009-11-11	2011-05-19	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2011063293A1 (en)	2009-11-20	2011-05-26	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antihelminth agents
US8716478B2 (en)	2010-01-27	2014-05-06	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
MX361011B (es)	2010-02-03	2018-11-26	Infinity Pharmaceuticals Inc	Inhibidores de amida hidrolasa de ácido graso.
WO2011116348A1 (en)	2010-03-19	2011-09-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agent
US8039494B1 (en)	2010-07-08	2011-10-18	Dow Pharmaceutical Sciences, Inc.	Compositions and methods for treating diseases of the nail
KR102087313B1 (ko)	2010-08-10	2020-03-11	렘펙스 파머수티클스 인코퍼레이티드	고리형 보론산 에스터 유도체의 제조방법
ES2635333T3 (es)	2010-09-07	2017-10-03	Anacor Pharmaceuticals, Inc.	Derivados de benzoxaborol para tratar infecciones bacterianas
WO2013033461A1 (en)	2011-08-31	2013-03-07	Rempex Pharmaceuticals, Inc.	Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
WO2013049424A1 (en)	2011-09-28	2013-04-04	Wisconsin Alumni Research Foundation	Catalytic conversion of cellulose to fuels and chemicals using boronic acids
BR112014008186A2 (pt) *	2011-10-07	2017-04-11	Syngenta Participations Ag	método para proteção de plantas úteis ou material de propagação de plantas
AR088669A1 (es)	2011-11-21	2014-06-25	Lilly Co Eli	Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
AR088668A1 (es)	2011-11-21	2014-06-25	Lilly Co Eli	Moleculas pequeñas que contienen boro
US9156858B2 (en)	2012-05-23	2015-10-13	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
US10561675B2 (en)	2012-06-06	2020-02-18	Rempex Pharmaceuticals, Inc.	Cyclic boronic acid ester derivatives and therapeutic uses thereof
WO2014007831A1 (en)	2012-07-06	2014-01-09	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
US9241947B2 (en)	2013-01-04	2016-01-26	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
US9101638B2 (en)	2013-01-04	2015-08-11	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
US9642869B2 (en)	2013-01-04	2017-05-09	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
EA201591004A1 (ru)	2013-01-04	2016-02-29	Ремпекс Фармасьютикалз, Инк.	Производные бороновой кислоты и их терапевтическое применение
US9585396B2 (en)	2013-01-30	2017-03-07	Agrofresh Inc.	Volatile applications against pathogens
US8669207B1 (en)	2013-01-30	2014-03-11	Dow Agrosciences, Llc.	Compounds and compositions
JP5927686B1 (ja) *	2013-01-30	2016-06-01	アグロフレッシュインコーポレイテッド	食肉、植物または植物の一部分に対する揮発性抗菌剤としてのベンゾオキサボロールの使用
US10070649B2 (en)	2013-01-30	2018-09-11	Agrofresh Inc.	Volatile applications against pathogens
US11039617B2 (en)	2013-01-30	2021-06-22	Agrofresh Inc.	Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9433680B2 (en)	2013-01-31	2016-09-06	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
US8778365B1 (en)	2013-01-31	2014-07-15	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
US9452173B2 (en)	2013-01-31	2016-09-27	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
US9446131B2 (en)	2013-01-31	2016-09-20	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
AP2015008638A0 (en)	2013-02-01	2015-08-31	Anacor Pharmaceuticals Inc	Boron-containing small molecules as antiprotozoal agents
AR094961A1 (es) *	2013-03-15	2015-09-09	Lilly Co Eli	1-hidroxi-benzooxaboroles como agentes antiparasitarios
AU2014202928B1 (en) *	2013-06-05	2014-09-11	Agrofresh Inc.	Compounds and compositions
CN104224810B (zh) *	2013-06-20	2017-04-19	中国科学院上海生命科学研究院	一种化合物及其衍生物治疗肺炎球菌感染性疾病的用途
KR101636431B1 (ko)	2013-07-30	2016-07-05	동아에스티 주식회사	트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
KR102093783B1 (ko)	2013-08-09	2020-03-26	글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드	트리시클릭 벤족사보롤 화합물 및 이의 용도
EP3052487B1 (en)	2013-10-03	2018-09-05	Dow Pharmaceutical Sciences, Inc.	Stabilized efinaconazole compositions
CN105848719A (zh)	2013-11-22	2016-08-10	道尔医药科学公司	抗感染的方法、组合物和装置
CN106029673B (zh)	2014-02-17	2018-12-21	先正达参股股份有限公司	杀微生物活性的苯并氧杂硼
WO2015134500A1 (en)	2014-03-03	2015-09-11	Cook Medical Technologies Llc	Mechanical dilator
JP2015212249A (ja)	2014-05-05	2015-11-26	アナコールファーマシューティカルズ，インコーポレイテッド	化合物および爪光沢剤
US9687497B1 (en)	2014-05-05	2017-06-27	Rempex Pharmaceuticals, Inc.	Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
ES2750805T3 (es)	2014-05-05	2020-03-27	Rempex Pharmaceuticals Inc	Síntesis de sales de boronato y usos de las mismas
CA2954803A1 (en) *	2014-05-12	2015-11-19	Agrofresh Inc.	Volatile applications against pathogens
AU2015264418A1 (en)	2014-05-19	2016-11-10	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
EP3164406A4 (en)	2014-07-01	2018-04-04	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
WO2016001834A1 (en)	2014-07-01	2016-01-07	Daiichi Sankyo Company, Limited	Tricyclic benzoxaboroles as antibacterial agents
AU2015336933B2 (en)	2014-10-21	2021-01-14	Deftbiotech Pty Ltd	A method of treatment
WO2016081297A1 (en)	2014-11-18	2016-05-26	Rempex Pharmaceuticals, Inc.	Cyclic boronic acid ester derivatives and therapeutic uses thereof
MA41494B1 (fr)	2015-02-12	2020-10-28	Glaxosmithkline Ip No 2 Ltd	Composés benzoxaborole substitués en position 4 et utilisations associées
WO2016149393A1 (en)	2015-03-17	2016-09-22	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
KR101580077B1 (ko) *	2015-03-28	2015-12-24	한국콜마주식회사	시크로피록스 함유 네일락카 조성물
AU2016246802A1 (en)	2015-04-09	2017-10-05	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
CN107872956B (zh) *	2015-04-09	2020-07-10	宾夕法尼亚州研究基金会	含有苯并氧杂硼戊环的协同性抗真菌组合物
US11174267B2 (en)	2015-06-12	2021-11-16	The Regents Of The University Of California	Spiroindolinones and therapeutic uses thereof
US10160867B2 (en) *	2015-08-06	2018-12-25	The Penn State Research Foundation	Benzoxaborole-containing coating resistant to cellulose-supportable fungus
CN106467557B (zh) *	2015-08-18	2019-05-03	北京海美桐医药科技有限公司	他瓦硼罗的一种制备方法
RU2724053C2 (ru) *	2015-11-30	2020-06-19	Анакор Фармасьютикалз, Инк.	Фармацевтические составы для местного применения для лечения связанных с воспалением состояний
EP3423065B1 (en)	2016-03-02	2021-07-21	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
EP3423159A4 (en) *	2016-03-02	2019-11-06	Anacor Pharmaceuticals, Inc.	BORN SMALL MOLECULES
US10874679B2 (en)	2016-03-02	2020-12-29	Bill & Melinda Gates Foundation	Boron-containing small molecules
AU2017229098B2 (en)	2016-03-07	2021-05-27	Agrofresh Inc.	Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
AU2017229096A1 (en)	2016-03-07	2018-09-06	Agrofresh Inc.	Vaporized administration of pesticides
US11447506B2 (en)	2016-05-09	2022-09-20	Anacor Pharmaceuticals, Inc.	Crystal forms of crisaborole in free form and preparation method and use thereof
AU2017262235C1 (en) *	2016-05-09	2020-08-20	Anacor Pharmaceuticals, Llc	Crystal forms of crisaborole in free form and preparation method and use thereof
DK3478693T3 (da)	2016-06-30	2021-09-20	Qpex Biopharma Inc	Boronsyrederivater og terapeutiske anvendelser deraf
EP3484895A1 (en)	2016-07-12	2019-05-22	Pliva Hrvatska D.O.O.	Solid state forms of crisaborole
US10743232B1 (en)	2016-11-15	2020-08-11	Sprint Spectrum L.P.	Controlling handover based on carrier-aggregation policies and UE capabilities
WO2018115362A1 (en)	2016-12-22	2018-06-28	Laboratorios Lesvi, Sl	Process for preparing 4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile (crisaborole)
GB201701583D0 (en) *	2017-01-31	2017-03-15	Drug Delivery Solutions Ltd	Topical composition
WO2018150327A1 (en) *	2017-02-14	2018-08-23	Wavelength Enterprises Ltd	Crisaborole production process
EP3576747A4 (en) *	2017-03-09	2020-12-16	The Penn State Research Foundation	SMALL MOLECULES CONTAINING BORON TO INHIBIT THE ACTIVITY OF A RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE
US10981939B2 (en)	2017-05-12	2021-04-20	Biophore India Pharmaceuticals Pvt. Ltd.	Process for the preparation of 4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl) oxy] benzonitrile (Crisaborole)
US10865217B2 (en)	2017-05-23	2020-12-15	Msn Laboratories Private Limited, R & D Center	Process for the preparation of 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole and polymorphs thereof
KR102626967B1 (ko)	2017-10-11	2024-01-18	큐펙스 바이오파마 인코포레이티드	보론산 유도체 및 이의 합성
PL3704100T3 (pl)	2017-11-02	2024-04-22	Halcyon Labs Private Limited	Nowy sposób wytwarzania tawaborolu i jego związków pośrednich
US11834466B2 (en) *	2017-11-30	2023-12-05	5Metis, Inc.	Benzoxaborole compounds and formulations thereof
US10329311B1 (en)	2017-12-21	2019-06-25	Olon S.P.A.	Process for the preparation of crisaborole
CN108148085B (zh)	2018-01-04	2019-11-01	合肥医工医药股份有限公司	具有抑制磷酸二酯酶4的化合物、制法及其药物用途
US11014944B2 (en)	2018-01-09	2021-05-25	Halcyon Labs Private Limited	Process for the preparation of crisaborole and its intermediates
US10597410B2 (en)	2018-02-02	2020-03-24	Dipharma Francis S.R.L.	Intermediates and process for the preparation of a crystalline form of a topical anti-inflammatory agent
CN108451898A (zh) *	2018-04-03	2018-08-28	苏州尚宜佳生物科技有限公司	一种克立硼罗温敏凝胶剂及其制备方法和应用
AU2019256351B2 (en)	2018-04-20	2024-02-29	Qpex Biopharma, Inc.	Boronic acid derivatives and therapeutic uses thereof
GB201809378D0 (en) *	2018-06-07	2018-07-25	Glaxosmithkline Ip Dev Ltd	Novel compounds
CN108659024A (zh) *	2018-07-24	2018-10-16	武汉轻工大学	克立硼罗的制备方法
KR20210039407A (ko) *	2018-07-31	2021-04-09	엠씨2 테라퓨틱스 리미티드	국소 조성물
BR112021003037A2 (pt)	2018-08-18	2021-05-11	Boragen, Inc.	formas sólidas de benzoxaborol substituído e composições do mesmo
JP7048823B2 (ja) *	2018-10-05	2022-04-05	ファイザー・インク	ホウ素含有ｐｄｅ４阻害剤
US20220160649A1 (en)	2019-03-20	2022-05-26	Rita DOBMEYER	Pharmaceutical composition
WO2021015841A1 (en) *	2019-07-25	2021-01-28	Massachusetts Institute Of Technology	Boron-containing pharmacophore
CN110664756B (zh) *	2019-10-09	2020-11-17	吉林大学	一种小儿外伤喷雾剂及其制备方法
US20230340530A1 (en)	2020-08-31	2023-10-26	Pfizer Inc.	Methods of Protecting RNA
CN114644645B (zh) *	2022-03-08	2023-05-26	南京农业大学	3-吲哚取代苯硼唑类化合物及其制备方法和应用
AU2023287202A1 (en) *	2022-06-23	2024-06-06	Shanghai Micurx Pharmaceutical Co., Ltd.	Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2260336A (en) *	1939-10-16	1941-10-28	Dow Chemical Co	Method of preparation of organic borates
US3686398A (en)	1970-07-20	1972-08-22	Chevron Res	10,9-boroxarophenanthrene as fungicides
GB1396904A (en) *	1972-08-11	1975-06-11	Ici Ltd	Method for the control of micro-organisms
US4602011A (en)	1975-10-24	1986-07-22	Chapman Chemical Company	Antimicrobial compositions and methods of using same
US4766113A (en)	1975-10-24	1988-08-23	Chapman Chemical Company	Antimicrobial compositions and methods of using same
US4716035A (en) *	1985-05-24	1987-12-29	The Procter & Gamble Company	Oral compositions and methods for treating gingivitis
US5962498A (en) *	1986-06-11	1999-10-05	Procyon Pharmaceuticals, Inc.	Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4894220A (en) *	1987-01-30	1990-01-16	Colgate-Palmolive Company	Antibacterial antiplaque oral composition
US4919934A (en)	1989-03-02	1990-04-24	Richardson-Vicks Inc.	Cosmetic sticks
US5514696A (en) *	1992-05-06	1996-05-07	Bristol-Myers Squibb Co.	Phenyl sulfonamide endothelin antagonists
SG47101A1 (en) *	1992-07-31	1998-03-20	Us Bioscience	Crystalline amifostine compositions and methods for the preparation and use of same
US5348948A (en) *	1993-05-07	1994-09-20	American Cyanamid Company	2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5348947A (en) *	1993-05-07	1994-09-20	American Cyanamid Company	Diarylboron ester and thioester fungicidal agents
US5594151A (en) *	1994-01-28	1997-01-14	Prolinx, Inc.	Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) *	1994-06-09	1994-08-03	Zeneca Ltd	Compound, composition and use
US5688258A (en)	1995-05-02	1997-11-18	The Procter & Gamble Company	Disposable cover for an absorbent materials
US6083903A (en) *	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
GB9500856D0 (en)	1995-01-17	1995-03-08	Zeneca Ltd	Composition and use
JPH09124620A (ja) *	1995-10-11	1997-05-13	Bristol Myers Squibb Co	置換ビフェニルスルホンアミドエンドセリン拮抗剤
US6766183B2 (en)	1995-11-22	2004-07-20	Medtronic Minimed, Inc.	Long wave fluorophore sensor compounds and other fluorescent sensor compounds in polymers
GB9604926D0 (en) *	1996-03-08	1996-05-08	Sandoz Ltd	Organic compounds
EP2223920A3 (en) *	1996-06-19	2011-09-28	Aventis Pharma Limited	Substituted azabicyclic compounds
US5831046A (en) *	1996-08-05	1998-11-03	Prolinx, Incorporated	Boronic acid-contaning nucleic acid monomers
WO1998012206A1 (en)	1996-09-19	1998-03-26	The Board Of Trustees Of Leland Stanford Jr. University	Dna adenine methyltransferases and uses thereof
WO1998024753A1 (fr)	1996-12-02	1998-06-11	Chisso Corporation	Derives de nitro-alcool actifs optiquement, derives d'amino-alcool actifs optiquement et leur procede de preparation
US6221640B1 (en)	1997-05-14	2001-04-24	Cubist Pharmaceuticals, Inc.	Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same
US6140328A (en)	1997-12-12	2000-10-31	Rutgers, The State University Of New Jersey	Heterocyclic cytotoxic agents
DE19829947A1 (de)	1998-07-04	2000-01-05	Bayer Ag	Elektrolumineszierende Anordnungen mit Bor-Chelaten
CA2350235A1 (en)	1998-11-06	2000-05-18	Basf Aktiengesellschaft	Tricyclic pyrazole derivatives
US6462036B1 (en)	1998-11-06	2002-10-08	Basf Aktiengesellschaft	Tricyclic pyrazole derivatives
EP1155698A4 (en)	1999-01-29	2003-01-15	Nitto Kasei Co Ltd	ORGANOBORAL COMPOUNDS HAVING COCCIDIOSTAT ACTIVITY
JP2003501431A (ja)	1999-05-25	2003-01-14	ザペンステートリサーチファウンデイション	Ｄｎａメチル基転移酵素阻害剤
DE60032614D1 (de)	1999-08-25	2007-02-08	Ambergen Inc	Verfahren zur erkennung, analyse und isolierung von freiwerdenden proteinen
US6306628B1 (en) *	1999-08-25	2001-10-23	Ambergen, Incorporated	Methods for the detection, analysis and isolation of Nascent proteins
US6921763B2 (en) *	1999-09-17	2005-07-26	Abbott Laboratories	Pyrazolopyrimidines as therapeutic agents
AU7995300A (en) *	1999-10-05	2001-05-10	Bethesda Pharmaceuticals, Inc.	Dithiolane derivatives
AU784597B2 (en)	2000-01-06	2006-05-11	Marantech Holding, Llc	Methods of using electron active compounds for managing cancer
US6521619B2 (en) *	2000-06-29	2003-02-18	Icos Corporation	Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
JP2004506417A (ja) *	2000-07-14	2004-03-04	ザイコス　インク．	α−ＭＳＨ関連化合物および使用方法
WO2002042273A2 (en)	2000-11-07	2002-05-30	Bristol-Myers Squibb Company	Acid derivatives useful as serine protease inhibitors
EP1339725B1 (en)	2000-11-30	2006-11-22	The Penn State Research Foundation	Dna methyl transferase inhibitors
DE10110051C2 (de) *	2001-03-02	2003-07-03	Clariant Gmbh	Verfahren zur Herstellung von Boron- und Borinsäuren
ES2332090T3 (es)	2001-04-06	2010-01-26	Biocryst Pharmaceuticals, Inc.	Compuestos biarilicos como inhibidores de serina proteasa.
GB0117645D0 (en) *	2001-07-19	2001-09-12	Isis Innovation	Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de) *	2001-09-07	2003-03-27	Clariant Gmbh	Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
JPWO2003033002A1 (ja)	2001-10-11	2005-02-03	御子柴　克彦	細胞内カルシウム濃度上昇抑制剤
JP4138662B2 (ja)	2002-01-10	2008-08-27	ザ・ペンシルバニア・ステイト・リサーチ・フアウンデイシヨン	アルキルジアリールボリネートおよび錯化ジアリールボロン酸を調製するための方法。
AU2003248921A1 (en) *	2002-07-09	2004-01-23	Point Therapeutics, Inc.	Boroproline compound combination therapy
EP1565452B1 (en)	2002-11-08	2012-04-04	Novartis International Pharmaceutical Ltd.	3-substituted-6-aryl pyridines as ligands of c5a receptors
US7446236B2 (en)	2002-12-02	2008-11-04	Solvias Ag	Catalytic hydrogenation of carbon-heteroatom double bonds
KR20050084378A (ko)	2002-12-18	2005-08-26	아나코르 파마슈티칼스 인코포레이티드	보린산 착물을 함유하는 항생제 및 그 이용방법
US7390806B2 (en)	2002-12-18	2008-06-24	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use
BRPI0408256A (pt)	2003-03-14	2006-03-01	Astrazeneca Ab	composto, métodos de tratamento de um humano ou animal, pela limitação da replicação de células, que sofre de cáncer, que sofre de uma doença neoplástica, e que se sofre de doenças proliferativas, uso de um composto, e, processo para a preparação de um composto ou de um seu sal farmaceuticamente aceitável ou de um éster hidrolisável in vivo do mesmo
US20050125852A1 (en) *	2003-05-09	2005-06-09	Sugen, Inc.	Novel kinases
CA2529792A1 (en) *	2003-06-16	2005-02-17	Anacor Pharmaceuticals, Inc.	Hydrolytically-resistant boron-containing therapeutics and methods of use
JP2005022986A (ja) *	2003-06-30	2005-01-27	Sankyo Co Ltd	Ｅｄｇ受容体拮抗作用を有するアルキン誘導体
EP1643998B1 (en)	2003-07-03	2007-08-29	F. Hoffmann-La Roche Ag	Dual nk1/nk3 antagonists for treating schizophrenia
AU2004312510A1 (en)	2003-12-29	2005-07-21	3M Innovative Properties Company	Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds
PT1755661E (pt) *	2004-05-12	2014-06-03	Brigham & Womens Hospital	A utilização de gelsolina para o tratamento de infeções
AR049915A1 (es)	2004-06-14	2006-09-13	Anacor Pharmaceuticals Inc	Compuestos con contenido de boro y metodos de uso de los mismos
KR100624238B1 (ko)	2004-06-22	2006-09-19	한국화학연구원	알파-아릴메톡시아크릴레이트 유도체를 함유하는 대사성골 질환의 예방 및 치료용 약학 조성물
US20060111388A1 (en)	2004-11-19	2006-05-25	University Of North Texas Health Science Center At Fort Worth	Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
GB0501944D0 (en)	2005-01-31	2005-03-09	Univ Cambridge Tech	Compounds for use in chemical detection and/or quantitation
SI3424932T1 (sl) *	2005-02-16	2021-08-31	Anacor Pharmaceuticals, Inc.	Boronoftalidi za terapevtsko uporabo
JP5084717B2 (ja)	2005-03-08	2012-11-28	エージェンシーフォーサイエンス，テクノロジーアンドリサーチ	キラル・ビスオキサゾリン触媒
TW200722087A (en) *	2005-03-30	2007-06-16	Astion Dev As	Treatment of dermatological diseases and pruritus
WO2007022437A2 (en)	2005-08-18	2007-02-22	Auspex Pharmaceuticals, Inc.	Therapeutic agents for the treatment of cancer and metabolic disorders
RU2008131324A (ru) *	2005-12-30	2010-02-10	Анакор Фармасьютикалз, Инк. (Us)	Борсодержащие малые молекулы
MX2008010381A (es)	2006-02-16	2009-03-05	Anacor Pharmaceuticals Inc	Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
AU2007257689A1 (en)	2006-06-12	2007-12-21	Anacor Pharmaceuticals, Inc.	Compounds for the treatment of periodontal disease
US20070286822A1 (en) *	2006-06-12	2007-12-13	Anacor Pharmaceuticals Inc.	Compounds for the Treatment of Periodontal Disease
KR100848491B1 (ko)	2007-01-16	2008-07-28	영진약품공업주식회사	베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar)	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
KR100895300B1 (ko)	2007-07-20	2009-05-07	한국전자통신연구원	생체신호 측정의복과 생체신호 처리시스템
WO2009111676A2 (en)	2008-03-06	2009-09-11	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-inflammatory agents
US8039450B2 (en)	2008-03-06	2011-10-18	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-inflammatory agents
US20100256092A1 (en)	2008-05-12	2010-10-07	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010028005A1 (en)	2008-09-04	2010-03-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010045503A1 (en)	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agents
WO2010045505A1 (en)	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-protozoal agents
AR088668A1 (es) *	2011-11-21	2014-06-25	Lilly Co Eli	Moleculas pequeñas que contienen boro
AR088669A1 (es) *	2011-11-21	2014-06-25	Lilly Co Eli	Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos

2006
- 2006-02-16 SI SI200632404T patent/SI3424932T1/sl unknown
- 2006-02-16 HU HUE15171026A patent/HUE040060T2/hu unknown
- 2006-02-16 US US11/357,687 patent/US7582621B2/en active Active
- 2006-02-16 DK DK15171026.6T patent/DK2987796T3/en active
- 2006-02-16 NZ NZ560448A patent/NZ560448A/en unknown
- 2006-02-16 DK DK18187390.2T patent/DK3424932T3/da active
- 2006-02-16 NZ NZ598441A patent/NZ598441A/xx unknown
- 2006-02-16 CN CNA2006800119809A patent/CN101160124A/zh active Pending
- 2006-02-16 SI SI200632291T patent/SI2987796T1/sl unknown
- 2006-02-16 ES ES18187390T patent/ES2872962T3/es active Active
- 2006-02-16 NZ NZ578297A patent/NZ578297A/en unknown
- 2006-02-16 PT PT181873902T patent/PT3424932T/pt unknown
- 2006-02-16 KR KR1020137021906A patent/KR101426220B1/ko active IP Right Grant
- 2006-02-16 KR KR1020137021530A patent/KR101456815B1/ko active IP Right Grant
- 2006-02-16 CA CA2597982A patent/CA2597982C/en active Active
- 2006-02-16 CN CN201010231477.2A patent/CN101914109B/zh active Active
- 2006-02-16 EP EP15171026.6A patent/EP2987796B1/en active Active
- 2006-02-16 PL PL11154575T patent/PL2343304T3/pl unknown
- 2006-02-16 PT PT67352823T patent/PT1853251E/pt unknown
- 2006-02-16 PL PL06735282T patent/PL1853251T3/pl unknown
- 2006-02-16 SI SI200631937T patent/SI2343304T1/sl unknown
- 2006-02-16 PL PL15171026T patent/PL2987796T3/pl unknown
- 2006-02-16 DK DK11154575.2T patent/DK2343304T3/en active
- 2006-02-16 KR KR1020107017187A patent/KR101337068B1/ko active IP Right Grant
- 2006-02-16 WO PCT/US2006/005542 patent/WO2006089067A2/en active Application Filing
- 2006-02-16 ES ES15171026.6T patent/ES2686981T3/es active Active
- 2006-02-16 ZA ZA200707408A patent/ZA200707408B/xx unknown
- 2006-02-16 KR KR1020077021229A patent/KR101337045B1/ko active IP Right Grant
- 2006-02-16 MX MX2015007465A patent/MX369262B/es unknown
- 2006-02-16 EP EP18187390.2A patent/EP3424932B1/en active Active
- 2006-02-16 ES ES06735282T patent/ES2414095T3/es active Active
- 2006-02-16 EP EP11154575.2A patent/EP2343304B1/en active Active
- 2006-02-16 EP EP06735282.3A patent/EP1853251B1/en active Active
- 2006-02-16 AU AU2006214247A patent/AU2006214247C1/en active Active
- 2006-02-16 ES ES11154575.2T patent/ES2540966T3/es active Active
- 2006-02-16 RU RU2007134429/04A patent/RU2414906C2/ru active
- 2006-02-16 HU HUE11154575A patent/HUE026021T2/en unknown
- 2006-02-16 PT PT15171026T patent/PT2987796T/pt unknown
- 2006-02-16 HU HUE18187390A patent/HUE054365T2/hu unknown
- 2006-02-16 JP JP2007555382A patent/JP5038912B2/ja active Active
- 2006-02-16 PT PT111545752T patent/PT2343304E/pt unknown
- 2006-02-16 PL PL18187390T patent/PL3424932T3/pl unknown
- 2006-02-16 BR BRPI0608431A patent/BRPI0608431B8/pt active IP Right Grant
2007
- 2007-08-06 IL IL185080A patent/IL185080A/en active IP Right Grant
2008
- 2008-03-11 HK HK08102801.7A patent/HK1109735A1/xx unknown
- 2008-03-11 HK HK12100416.2A patent/HK1160139A1/xx not_active IP Right Cessation
2009
- 2009-07-21 US US12/507,010 patent/US8039451B2/en active Active
- 2009-08-27 ZA ZA2009/05950A patent/ZA200905950B/en unknown
2010
- 2010-07-20 AU AU2010203096A patent/AU2010203096C1/en active Active
- 2010-07-22 IL IL207156A patent/IL207156A/en active Protection Beyond IP Right Term
- 2010-07-28 ZA ZA2010/05380A patent/ZA201005380B/en unknown
- 2010-08-05 JP JP2010175989A patent/JP6046876B2/ja active Active
- 2010-08-10 RU RU2010133524A patent/RU2606947C2/ru active
2011
- 2011-03-01 AU AU2011200994A patent/AU2011200994A1/en not_active Abandoned
- 2011-09-01 US US13/224,252 patent/US8440642B2/en active Active
2012
- 2012-09-20 JP JP2012207001A patent/JP2013018778A/ja active Pending
2013
- 2013-04-30 US US13/874,329 patent/US8889656B2/en active Active
2014
- 2014-01-27 US US14/165,428 patent/US20140142064A1/en not_active Abandoned
- 2014-04-09 JP JP2014080464A patent/JP2014132031A/ja active Pending
- 2014-11-10 US US14/537,694 patent/US20150065459A1/en not_active Abandoned
2015
- 2015-09-17 ZA ZA2015/06944A patent/ZA201506944B/en unknown
- 2015-09-24 JP JP2015187408A patent/JP2016020374A/ja active Pending
- 2015-12-21 US US14/977,052 patent/US20160108063A1/en not_active Abandoned
2016
- 2016-08-23 HK HK16110032.1A patent/HK1221956A1/zh unknown
- 2016-11-18 US US15/355,813 patent/US20170066788A1/en not_active Abandoned
- 2016-11-23 RU RU2016145916A patent/RU2016145916A/ru not_active Application Discontinuation
2017
- 2017-02-15 JP JP2017025789A patent/JP2017105826A/ja active Pending
2018
- 2018-09-18 CY CY181100962T patent/CY1120695T1/el unknown
- 2018-10-18 US US16/164,331 patent/US20190048026A1/en not_active Abandoned
2019
- 2019-07-12 US US16/510,135 patent/US20190330245A1/en not_active Abandoned
2020
- 2020-06-08 LU LU00157C patent/LUC00157I2/fr unknown
- 2020-06-23 FR FR20C1024C patent/FR20C1024I2/fr active Active
- 2020-06-24 NL NL301049C patent/NL301049I2/nl unknown
- 2020-06-25 HU HUS2000019C patent/HUS2000019I1/hu unknown
- 2020-07-30 CY CY2020027C patent/CY2020027I1/el unknown
- 2020-08-14 LT LTPA2020524C patent/LTC2343304I2/lt unknown
- 2020-11-16 US US17/098,636 patent/US20210070780A1/en not_active Abandoned
2021
- 2021-05-19 CY CY20211100432T patent/CY1124503T1/el unknown

Also Published As

Publication number	Publication date
KR20100105869A (ko)	2010-09-30
US20210070780A1 (en)	2021-03-11
JP6046876B2 (ja)	2016-12-21
WO2006089067A3 (en)	2007-07-19
PT2343304E (pt)	2015-08-26
IL185080A (en)	2012-07-31
KR20070112390A (ko)	2007-11-23
CA2597982C (en)	2014-07-08
CY1120695T1 (el)	2019-12-11
NL301049I2 (nl)	2020-09-10
US20190048026A1 (en)	2019-02-14
HUE026021T2 (en)	2016-05-30
ZA200707408B (en)	2009-11-25
US8889656B2 (en)	2014-11-18
ZA201506944B (en)	2018-08-29
IL207156A (en)	2014-04-30
DK2343304T3 (en)	2015-06-29
RU2414906C2 (ru)	2011-03-27
US8039451B2 (en)	2011-10-18
DK3424932T3 (da)	2021-05-25
CY2020027I2 (el)	2021-01-27
JP2014132031A (ja)	2014-07-17
CA2597982A1 (en)	2006-08-24
EP2343304A1 (en)	2011-07-13
BRPI0608431A2 (pt)	2009-12-29
HUE054365T2 (hu)	2021-09-28
US20150065459A1 (en)	2015-03-05
PL1853251T3 (pl)	2013-09-30
LTPA2020524I1 (lt)	2020-09-10
HK1109735A1 (en)	2008-06-20
JP2017105826A (ja)	2017-06-15
LUC00157I1 (sl)	2020-06-08
JP2010248265A (ja)	2010-11-04
US20170066788A1 (en)	2017-03-09
EP2987796B1 (en)	2018-08-08
RU2606947C2 (ru)	2017-01-10
RU2010133524A (ru)	2012-02-20
BRPI0608431B8 (pt)	2021-05-25
HK1221956A1 (zh)	2017-06-16
KR101337068B1 (ko)	2013-12-06
EP1853251A4 (en)	2010-01-13
CN101914109A (zh)	2010-12-15
LTC2343304I2 (lt)	2022-11-10
WO2006089067A2 (en)	2006-08-24
PT3424932T (pt)	2021-05-19
JP5038912B2 (ja)	2012-10-03
PT1853251E (pt)	2013-07-19
PL3424932T3 (pl)	2021-09-20
NZ578297A (en)	2010-11-26
ZA200905950B (en)	2010-11-24
KR101426220B1 (ko)	2014-08-05
CN101914109B (zh)	2014-07-23
EP1853251A2 (en)	2007-11-14
NZ560448A (en)	2009-08-28
PL2987796T3 (pl)	2018-12-31
AU2006214247A1 (en)	2006-08-24
CY2020027I1 (el)	2021-01-27
FR20C1024I2 (fr)	2021-07-09
JP2016020374A (ja)	2016-02-04
ES2872962T3 (es)	2021-11-03
LUC00157I2 (sl)	2021-07-06
HUS2000019I1 (hu)	2020-07-28
RU2016145916A (ru)	2018-05-23
US20100190748A1 (en)	2010-07-29
US20130244980A1 (en)	2013-09-19
JP2008535781A (ja)	2008-09-04
KR20130095330A (ko)	2013-08-27
BRPI0608431B1 (pt)	2020-09-15
HUE040060T2 (hu)	2019-02-28
SI2987796T1 (sl)	2018-11-30
AU2011200994A1 (en)	2011-03-31
MX369262B (es)	2019-11-04
US8440642B2 (en)	2013-05-14
ES2686981T3 (es)	2018-10-23
US7582621B2 (en)	2009-09-01
US20160108063A1 (en)	2016-04-21
FR20C1024I1 (sl)	2020-07-31
EP1853251B1 (en)	2013-04-24
SI2343304T1 (sl)	2015-08-31
EP2343304B1 (en)	2015-06-10
RU2007134429A (ru)	2009-03-27
AU2006214247C1 (en)	2012-11-08
US20190330245A1 (en)	2019-10-31
AU2010203096A1 (en)	2010-08-12
CY1124503T1 (el)	2022-07-22
JP2013018778A (ja)	2013-01-31
EP2987796A1 (en)	2016-02-24
NL301049I1 (nl)	2020-07-01
RU2016145916A3 (sl)	2020-07-21
AU2010203096B2 (en)	2010-12-02
ES2540966T3 (es)	2015-07-15
IL185080A0 (en)	2008-08-07
KR101337045B1 (ko)	2013-12-05
HK1160139A1 (en)	2012-08-10
EP3424932B1 (en)	2021-04-07
KR101456815B1 (ko)	2014-10-31
DK2987796T3 (en)	2018-09-17
PT2987796T (pt)	2018-10-18
PL2343304T3 (pl)	2015-09-30
ZA201005380B (en)	2016-08-31
AU2006214247B2 (en)	2010-08-05
CN101160124A (zh)	2008-04-09
US20110319361A1 (en)	2011-12-29
NZ598441A (en)	2013-07-26
KR20130100019A (ko)	2013-09-06
EP3424932A1 (en)	2019-01-09
US20060234981A1 (en)	2006-10-19
ES2414095T3 (es)	2013-07-18
US20140142064A1 (en)	2014-05-22
AU2010203096C1 (en)	2012-09-20

Publication	Publication Date	Title
PT3424932T (pt)	2021-05-19	Boronoftalidas para utilização terapêutica
GB0518390D0 (en)	2005-10-19	Therapeutic compounds
GB0506147D0 (en)	2005-05-04	Therapeutic agents
GB0518237D0 (en)	2005-10-19	Therapeutic compounds
GB0509326D0 (en)	2005-06-15	Therapeutic compounds
GB0509573D0 (en)	2005-06-15	Therapeutic compounds
GB0518361D0 (en)	2005-10-19	Therapeutic compounds
GB0519797D0 (en)	2005-11-09	Therapeutic agents
GB0522881D0 (en)	2005-12-21	Therapeutic compounds
GB0505725D0 (en)	2005-04-27	Therapeutic agents
GB0505437D0 (en)	2005-04-20	Therapeutic agents
GB0509405D0 (en)	2005-06-15	Therapeutic compounds
GB0518819D0 (en)	2005-10-26	Therapeutic agents
GB0518817D0 (en)	2005-10-26	Therapeutic agents
GB0513747D0 (en)	2005-08-10	Therapeutic compounds
GB0516661D0 (en)	2005-09-21	Therapeutic agents
GB0514738D0 (en)	2005-08-24	Therapeutic agents
GB0522130D0 (en)	2005-12-07	Therapeutic compounds
GB0526107D0 (en)	2006-02-01	Therapeutic Compounds
GB0507003D0 (en)	2005-05-11	Therapeutic
GB0518235D0 (en)	2005-10-19	Therapeutic compounds
GB0501655D0 (en)	2005-03-02	Therapeutic use
GB0518720D0 (en)	2005-10-19	Therapeutic combination
GB0523998D0 (en)	2006-01-04	Therapeutic agents
GB0515580D0 (en)	2005-09-07	Therapeutic compounds